Italy: number of biotech orphan drugs drugs marketed 2016-2017, by type
This statistic depicts the number of biotech orphan drugs available on the Italian pharmaceutical market between 2016 and 2017, by type. According to data, most of the biotech products available aimed at treating rare diseases were based on proteins obtained through recombinant DNA (15 treatments). Pertaining to gene therapy and tissue engineering only one treatment each was available in Italy up to 2017.